
New technology will be used to develop and produce mRNA therapeutic drugs and vaccines in Adelaide, helping to address Australia's supply issues highlighted by the COVID-19 pandemic.
Thanks to $10 million from the SA and federal governments, the BioCina pharmaceutical production facility will become an mRNA centre of excellence, to support the scale-up and production of drugs and vaccines within two years.